Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective.
Pharmaceutical companies spend over $45B a year running clinical trials, which are, by design, very methodical and measured. Unfortunately, they are also slow, unpredictable...
Decentralized digital therapeutic trial. Pear Therapeutics has enrolled the first participant in the DREAM study, an open-label trial of its Somryst prescription digital therapeutic for chronic insomnia.
Conducted as a decentralized trial, the effort will recruit U.S. adults aged 22 to 75 years who have an Insomnia Severity Index score of 8 or higher, as well as at least three months of insomnia...
Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials.
The company's drug-development-focused contract research organization (CRO), Covance, will use digital clinical trial software-maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps...
Cloud technology opens up the potential for exciting innovations when it comes to the design and execution of clinical trials, but data security and privacy concerns are holding innovation at a snail’s pace.
Despite these misgivings, cloud-based solutions could in fact offer greater security, as well as the ability to access large pools of data that would improve an organization’s ability to...
Healthcare is in the midst of a digital shift. Artificial intelligence offers physicians providers an new resource when making decisions, new data streams promise hyper-personalized treatments and digital therapeutics evangelists see are hawking the novel treatments as a companion, or even a replacement, to traditional biologic treatments. All in all, it’s a future that hopes to empower the...
This morning Verily announced a series of new strategic partnerships with four global pharmaceutical companies that will bring low-burden digital data collection and analysis tools to clinical research projects.
Alongside Novartis, Otsuka, Pfizer and Sanofi, the Alphabet subsidiary will employ its Project Baseline platform to increase the number and diversity of study populations by making it...
Teckro, a Limerick, Ireland-based maker of clinical trial software, has raised $25 million in Series C funding, bringing the company’s total backing to $43 million. TechCrunch, Reuters and others report that the round was led by Northpond Ventures, with additional support from Section 32, Founders Fund, Sands Capital Ventures and Borealis Ventures.
What they do
Teckro’s digital offering collects...
Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception.
This week Boston was host to the Biotechnology Innovation Organization’s annual conference, a multi-day gathering of leading pharma and biotech leaders from across the globe. While, admittedly, digital health wasn’t always the primary interest of many attendees and speakers, it was...
Novartis announced yesterday that it has launched an app specifically designed for eye patients to participate in ophthalmic clinical trials.
Built with ResearchKit, the FocalView app looks to improve data captured by allowing patients interested in participating to conveniently self-report their conditions through their smartphone, thereby providing researchers with a greater wealth of time-...
Pharma companies have been eying digital health with interest, and the first quarter of 2018 was no exception. With the exception of some medication adherence-focused technologies — such as an edible QR code intended to assist with medication dosing — news tended to center around digitally-enabled clinical trials, rollouts or pilots of pharma-focused digital tools, and major deals or...
